Program delivering life-saving Australian-made antivenoms to PNG extended another three years
A partnership involving CSL Seqirus, and which has saved more than 2,000 lives through access to antivenoms in Papua New Guinea since beginning in 2018, has been extended by another three years out until 2027. According to a statement from CSL Seqirus – a division of ASX-listed biotech company CSL – it is an initiative…